Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers to prevent end-stage kidney disease in patients who do not have diabetes.
Strippoli
Giovanni F M
GF
Centre for Kidney Research, Cochrane Renal Group, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia. gfmstrippoli@katamail.com
Jonathan
Craig C
CC